RECURRENT ADULT BURKITT LYMPHOMA
Clinical trials for RECURRENT ADULT BURKITT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADULT BURKITT LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT ADULT BURKITT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test re-engineered 'Living Drug' to hunt lymphoma
Disease control OngoingThis early-phase study is testing the safety and best dose of a personalized cell therapy for patients with aggressive B-cell lymphomas that have returned or are high-risk. The treatment involves collecting a patient's own immune cells (T cells), genetically modifying them in a l…
Matched conditions: RECURRENT ADULT BURKITT LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists re-engineer Patient's own cells to hunt down blood cancers
Disease control OngoingThis early-stage study is testing a new type of cellular immunotherapy for adults whose B-cell lymphoma or leukemia has come back. Doctors collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer cells, and then infuse them back…
Matched conditions: RECURRENT ADULT BURKITT LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New strategy aims to tame dangerous virus after cancer transplant
Disease control OngoingThis study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…
Matched conditions: RECURRENT ADULT BURKITT LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC